FDA Commissioner: Addressing Revolving Door Between Agency & Pharma is a 'Delicate Area'

Name: FDA Commissioner: Addressing Revolving Door Between Agency & Pharma is a 'Delicate Area'
Uploaded: 2024-04-12T01:59:28+00:00
Duration: P185S
Description: FDA Commissioner Dr. Robert Califf Says Addressing the Revolving Door Between the Agency &amp; the Pharmaceutical Industry is a &apos;Delicate

Credit: Rumble

Duration: 03:05s 12 Apr 2024 0 shares 1 views

FDA Commissioner: Addressing Revolving Door Between Agency & Pharma is a 'Delicate Area'

FDA Commissioner Dr. Robert Califf Says Addressing the Revolving Door Between the Agency & the Pharmaceutical Industry is a 'Delicate Area'

FDA Commissioner: Addressing Revolving Door Between Agency & Pharma is a 'Delicate Area'

You might like